Tse, GaryAriti, ConoBafadhel, MonaPapi, AlbertoCarter, Victoria AZhou, JiandongSkinner, DerekXu, XiaoMüllerová, HanaEmmanuel, BenjaminPrice, David2025-02-272025-02-272025-01Tse, G, Ariti, C, Bafadhel, M, Papi, A, Carter, V A, Zhou, J, Skinner, D, Xu, X, Müllerová, H, Emmanuel, B & Price, D 2025, 'Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD', Advances in Therapy, vol. 42, pp. 375–394. https://doi.org/10.1007/s12325-024-03024-30741-238Xhttps://hdl.handle.net/2164/25099ACKNOWLEDGMENTS Author Contributions. All authors made a significant contribution to the work reported. David Price and Victoria Carter contributed to study conception or design, data acquisition, data analysis, and data interpretation. Mona Bafadhel and Alberto Papi contributed to data interpretation. Gary Tse, Cono Ariti, and Jiandong Zhou contributed to data analysis and data interpretation. Derek Skinner contributed to data acquisition, data analysis, and data interpretation. Xiao Xu, Hana Müllerová, and Benjamin Emmanuel contributed to study conception or design and data interpretation. All authors took part in drafting, revising, or critically reviewing the article, gave final approval of the version to be published, have agreed on the journal to which the article has been submitted, and agree to be accountable for all aspects of the work.202960210engChronic obstructive pulmonary diseaseCohort studyCorticosteroidsCosthealthcare resource utilizationObservationalPrimare careR MedicineSupplementary DataRJournal article10.1007/s12325-024-03024-342